Please join us for our 5th Annual Corporate & Securities Counsel Public Company Forum. This virtual half-day program will feature panel discussions focused on timely and practical guidance related to the latest developments...more
11/28/2023
/ Board of Directors ,
Capital Markets ,
Clawbacks ,
Climate Change ,
Continuing Legal Education ,
Corporate Governance ,
Cybersecurity ,
Fiduciary Duty ,
Glass Lewis ,
Insider Trading ,
Institutional Shareholder Services (ISS) ,
Non-GAAP Financial Measures ,
PCAOB ,
Publicly-Traded Companies ,
Risk Management ,
Securities and Exchange Commission (SEC) ,
Securities Regulation ,
Shareholder Activism ,
Stock Repurchases ,
Universal Proxy ,
Webinars
Following up on our prior blog post regarding 2020 first quarter COVID-19 adjustments in connection with the presentation of non-GAAP financial measures, we surveyed 102 S&P 500 companies who presented Adjusted EBITDA in...more
One of the key areas of disclosure focus for the Securities and Exchange Commission (SEC) following the emergence of the COVID-19 pandemic was the impact that the pandemic might have on the presentation of non-GAAP financial...more
The recent SEC enforcement action against ADT Inc. for its failure to comply with the SEC’s equal prominence requirements applicable to non-GAAP financial measures, as outlined in our recent blog post, is a clear reminder...more
10/24/2019
/ C&DIs ,
CD&A ,
EBITDA ,
Enforcement Actions ,
Form 8-K ,
Investor Protection ,
Non-GAAP Financial Measures ,
Proxy Statements ,
Public Disclosure ,
Publicly-Traded Companies ,
Regulation G ,
Regulation S-K ,
Securities and Exchange Commission (SEC)
While developments with respect to the Management’s Discussion and Analysis of Financial Condition and Results of Operations (MD&A) section in SEC disclosure documents has garnered less attention in the legal press in recent...more